Tuesday, September 23, 2025

10:30 AM - 12:00 PM

Grand Copthorne Waterfront Hotel - Grand Ballroom I

---

Details

Long-acting injectable formulations are now a reality as maintenance therapy for many diseases, including infectious diseases. Today we have LAI antibiotics for the chronic therapy of osteoarticular infections, LAI antiretrovirals for the treatment of people with HIV and, more recently also LAI formulations of echinocandins for the treatment of fungal infections. These drugs are often given at fixed intervals, despite preliminary evidence of considerable pharmacokinetic variability. This symposium will address the possible role of TDM as a tool to personalise the frequency of administration of long-acting anti-infectious drugs. It is also thought to introduce a reading on the applications of TDM for long-acting formulations of antipsychotics, as an example to be followed in the field of infectious diseases.